#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Diffuse large B-cell lymphoma refractory Langerhans' cell histiocytosis Colorectal adenocarcinoma Meningococcal immunisation Advanced systemic mastocytosis Cervix carcinoma Rectal cancer Leukoencephalopathy Desmoid tumour Congenital cystic kidney disease Eosinophilic granulomatosis with polyangiitis Philadelphia chromosome positive Solitary fibrous tumour Glioblastoma Breast angiosarcoma metastatic More trials…

    Learn about Rare Diseases

    Paroxysmal nocturnal haemoglobinuria Mantle cell lymphoma refractory – Basic Information Lymphangioma – Basic Information Primary biliary cholangitis – Diagnostics Leiomyosarcoma recurrent – Trials in Disease Mantle cell lymphoma – Life with Disease Cystic fibrosis lung – Basic Information Factor IX deficiency Nephroblastoma – Basic Information Angiosarcoma non-metastatic – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Guselkumab PICLIDENOSON Hexaminolevulinate Efinopegdutide Rosuvastatin Zinc Sar-443579 Ranolazine Paroxetine Ivabradine Hydrochloride NALMEFENE HYDROCHLORIDE Immunoglobulins, Normal Human Fampridine GSKVX000000046019 Concizumab ASP3082 Hhalpc Formoterol Fumarate Bendamustine Hydrochloride IPN01195 Setrusumab More therapies…

    Learn about Your Condition

    Lymphatic malformation Lung adenocarcinoma stage III Round cell liposarcoma Aplastic anaemia Tendon rupture Periarthritis BRAF gene mutation Lymphangiosarcoma Polymyositis White matter lesion Endometrial cancer stage II Cold urticaria Laryngeal cancer Renal disorder Ear discomfort More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hopitaux Universitaires Pitie Salpetriere

Hopitaux Universitaires Pitie Salpetriere

47 Boulevard De L Hopital, Paris, 75651, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

    Not yet recruiting

    3 1
    Austria Belgium Bulgaria Czechia Denmark France +11

  • Study on Adjusting Adalimumab Treatment for Patients with Chronic Non-Infectious Uveitis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Infective uveitis
    Investigated Drugs:
    • Adalimumab
    France

  • Study on Glioblastoma Treatment with Temozolomide, Lomustine, and Perflutren for Newly Diagnosed Patients

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Perflutren
    • Lomustine
    • Temozolomide
    Belgium France

  • Study on Maintenance Therapy with OSE2101 and FOLFIRI for Patients with Advanced Pancreatic Cancer After Initial FOLFIRINOX Treatment

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Ductal adenocarcinoma of pancreas
    Investigated Drugs:
    • D-Ala-Lys-Cha-Val-Ala-Ala-Trp-Thr-Leu-Lys-Ala-Ala-D-Ala
    • Levoleucovorin
    • Mps-102
    France

  • Study Comparing Chemotherapy Alone to Dostarlimab, Paclitaxel, and Carboplatin for Patients with Advanced or Metastatic Endometrial Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    Investigated Drugs:
    • Dostarlimab
    • Carboplatin
    • Paclitaxel
    France Italy Romania Spain

  • Study on the Effects of OATD-01 for Patients with Active Pulmonary Sarcoidosis

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Pulmonary sarcoidosis
    Investigated Drugs:
    • 5-(4-((2S,5S)-5-(4-Chlorobenzyl)-2-Methylmorpholino)Piperidin-1-Yl)-1H- 1,2,4-Triazol-3-Amine
    Denmark France Germany Greece Norway Poland

  • Study on HIV-1 Treatment for Patients New to Therapy: Comparing Doravirine/Islatravir with a Drug Combination

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Bictegravir
    • Doravirine
    • Islatravir
    France Germany Italy The Netherlands Poland Spain

  • Study on Doravirine and Islatravir for People with HIV-1 Previously Treated with the Same Drug Combination

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Doravirine
    • Islatravir
    Finland France Germany Italy Poland Spain

  • Study on Switching HIV Treatment to Doravirine and Islatravir for Patients with HIV-1

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Bictegravir
    • Doravirine
    • Islatravir
    France Germany Italy Spain

  • Study of Baricitinib for Treating Hospital-Acquired Pneumonia in Critically Ill Patients with a Proinflammatory Profile

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Baricitinib
    Belgium France The Netherlands Spain
Previous Page
1 … 8 9 10 11 12 … 20
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!